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Abstract 
Purpose: To investigate the antioxidant and anti-inflammatory effects of Ulmus davidiana extract (UDE) 
in lipopolysaccharide (LPS)-stimulated BV-2 cells. 
Methods: Antioxidant activity was measured using 1, 1-diphenyl-2-picryl-hydrazyl (DPPH) radical 
scavenging assay. Cell viability was evaluated using 3-(4, 5-dimethylthiazol-2-yl)-2, 5- 
diphenyltetrazolium bromide (MTT) assay. BV-2 cells were stimulated with LPS to study protein 
expression and production of inflammatory mediators, and determined by Western blot analysis. 
Results: UDE significantly inhibited DPPH-generated free radicals showing maximum inhibition at 40 
μg/mL (p < 0.001). UDE alone did not exhibit any signs of cytotoxicity towards BV-2 cells up to 100 
μg/mL concentration. The LPS-induced increase in the production of nitric oxide was concentration-
dependently suppressed with half-maximal concentration (IC50) of 67.4 µg/ mL of UDE (p < 0.05 at 10 
μg/mL, p < 0.01 at 20 μg/mL and p < 0.001 at 40 μg/mL, respectively). UDE also inhibited dose-
dependently the LPS-induced increase in inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 
(COX-2) expressions with IC50 of 52.3 ug/ mL. Furthermore, the production of pro-inflammatory 
cytokines, via tumor necrosis factor-α by LPS-stimulation in BV2 murine cells was inhibited dose-
dependently with IC50 of 85.1 ug/ mL by UDE pretreatment. Mechanistic studies revealed that UDE acts 
by regulation of nuclear factor kappa-B signaling pathway in LPS-stimulated BV-2 cells. 
Conclusion: This study shows, for the first time, that UDE possesses antioxidant and anti-inflammatory 
effects and can be developed as a potential therapeutic agent for ameliorating macrophage-mediated 
inflammation.  
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Ulmus davidiana var. japonica (UDE), from the 
family of Ulmaceae, is widely distributed in 
Korea, Japan, and China. The stem and root 
barks of this plant are traditionally used to treat 
diarrhea, edema, jaundice, hepatitis, and gastric 
cancer [1]. Its proven medicinal potency merits 
an elucidation of the mechanisms by which it 
works and this study will focus on the molecular 
activities of UDE on BV2 murine microglial cells. 
 
UDE can be used to promote diuresis and to 
treat dampness [1] It is composed of various 
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sesquiterpenes, triterpenes, lignans, and 
flavonoids [2]. Previous studies have shown that 
UDE or its isolated components have various 
effects, including anti-oxidation [2,3], anti-
inflammatory [3], and possibly anti-angiogenic 
effect [4]. 
 
Neuro-inflammation mediated by microglial 
activation appears to play an essential role in the 
pathogenesis of various neuro-degenerative 
diseases such as Alzheimer’s disease, 
Parkinson’s disease and multiple sclerosis [5].  
Microglia under activated conditions releases 
several inflammatory cytokines and toxic free 
radicals, which may contribute to the 
neurodegenerative process. Previous reports 
demonstrate that suppressive agents of the 
inflammatory mediator concentrations in 
activated microglia can attenuate the severity of 
neuro-degenerative diseases [6]. 
 
It is well documented that the pathophysiological 
condition in inflammatory disorders is initiated by 
a complex processes triggered by microbial 
endotoxins like LPS, which can directly activate 
microglia, thus triggering the production of 
inflammatory mediators, such as NO, COX-2, 
pro-inflammatory cytokines and leukotrienes [7]. 
Therefore, LPS-induced inflammatory mediators 
in vitro can be regarded as one of the essential 
tools for evaluating the deleterious 
consequences of excessive activation of 
microglia. Recent studies have shown that 
antioxidant and anti-inflammatory agents may 
suppress microglial activation and thus protect 
neuronal cell death [8].  
 
In this study, the in vitro antioxidant potential and 
anti-neuroinflammatory properties of UDE were 
evaluated in LPS- and interferon-γ-stimulated 




Preparation of U. davidiana extract  
 
Dried plant material of U. davidiana purchased 
from a market specializing in herbs (Traditional 
herb market; Seoul, Korea). It was authenticated 
by Prof Chang-Kyu Oh, a taxonomist at Dankook 
University, South Korea authenticated. A voucher 
specimen (UD-DKU2015) was stored in 
Department of Medical Laboratory Science, 
Dankook University for future reference. To 
obtain the U. davidiana extract, the dried plant 
material was ground in a blender.  The powdered 
material was extracted with 10 volumes (v/w) of 
70 % ethanol at room temperature for 72 h and 
filtered. The residue was extracted with absolute 
ethanol at 1:10 ratio (w/v) for 2 h in a heating 
mantle at 70 - 80 °C, and the supernatant was 
filtered and concentrated in a vacuum evaporator 
system at 50 °C. For further fractionation, the 
extract (1000 mg) was partitioned into hexane, 
chloroform and ethyl acetate (EA) fractions to 
yield 267, 73 and 307 mg, respectively. The 
active EA fraction of U. davidiana (UDE) was re-
dissolved in distilled water. 
 
DPPH radical scavenging activity  
 
This assay was based on the scavenging of 
stable 2, 2-diphenyl-1-picrylhydrazyl (DPPH, 
Sigma-Aldrich, St. Louis, MO, USA) radicals by 
the radical scavenging antioxidants in UDE. The 
radical scavenging capacity was evaluated by 
employing a reaction mixture constituted by 
aliquots of the UDE and a DPPH methanolic 
solution as described previously [8]. A sample 
solution of 60 µL of each UDE was added to 60 
µL of DPPH (60 µM) in methanol. After mixing 
vigorously for 10 s, the mixture was transferred 
into a 100 µL Teflon capillary tube and the 
scavenging activity of each sample on DPPH 
radical was measured using a JES-FA ESR 
spectrometer (Jeol Ltd., Tokyo, Japan). A spin 
adduct was measured on an ESR spectrometer 
exactly after 2 min. Experimental conditions were 
as follows: central field, 3,475 G; modulation 
frequency, 100 kHz; modulation amplitude, 2 G; 
microwave power, 5 mW; gain, 6.3 x 105, and 
temperature, 298 °K. 
 
Cell cultures and viabilities 
 
BV2 murine microglia cells were cultured at 37 
°C in 5 % CO2 in DMEM (Invitrogen, Carlsbad, 
CA, USA) supplemented with 5 % Fetal Bovine 
Serum (FBS, Hyclone, Logan, UT, USA) and 
antibiotics (Invitrogen). Cell viability was 
determined by 3-(4, 5- dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay as 
described previously [8]. In all experiments, cells 
were pre-treated with the indicated 
concentrations of UDE for 1 h before the addition 
of LPS (1 μg/mL, Sigma-Aldrich, St. Louis, MO, 
USA) in serum free DMEM. An equal volume of 
sterile water was added to all control treatments. 
Cells were incubated with various UDE 
concentrations for 24 h followed by MTT for 4 h, 
and then 100 μl of isopropanol (in 0.04 N-
hydrochloric acid) was added to dissolve the 
formazan crystals. The absorbance was read at 
570 nm using the Biochrom Anthos 2010 
spectrophotometer (Salzburg, Austria). Cell 
viability was measured by the relative 
absorbances of the samples compared to the 
control. 
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BV2 murine microglial cells were grown in 
RPMI1640 (Invitrogen, Carlsbad, CA, USA), 
supplemented with 10 % FBS (Hyclone, Logan, 
UT, USA) containing 100 U/mL of penicillin 
(Invitrogen), and 100 μg/mL streptomycin 
(Invitrogen) in 37 °C in humidified atmosphere of 
5 % CO2. In all experiments, cells were pre-
treated with the indicated concentrations of UDE 
for 1 h before the addition of LPS (1 µg/mL, 
Sigma-Aldrich, St. Louis, MO, USA) in serum 
free RPMI1640. An equal volume of sterile water 
was added to all control treatments. Cell viability 
was determined by 3-(4, 5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay as 
described previously [8]. Cells were incubated 
with various concentrations of UDE for 24 h 
followed by MTT for 4 h, and then 100 μL of 
isopropanol (in 0.04 N-hydrochloric acid) was 
added to dissolve the formazan crystals. The 
absorbance was read at 570 nm using the 
spectrophotometer (Tecan, USA). Cell viability 
was calculated as relative absorbance compared 
to control. 
 
Nitric oxide assay 
 
The amount of stable nitrite, the end product of 
NO generation, inactivated microglia was 
determined by a colorimetric assay as previously 
described [8]. Each supernatant was mixed with 
the same volume of Griess reagent (1 % 
sulfanilamide in 5 % phosphoric acid and 0.1 % 
naphthyl ethylenediamine dihydrochloride in 
water). The absorbance of the mixture at 540 nm 
was determined with an ELISA reader (Bio-Tek 
Instrument, Winooski, VT, USA). Nitrite 
concentration was determined by extrapolation 
from a sodium nitrite standard curve.  
 
Nuclear protein extraction and Western blot 
analysis  
 
Cells were washed in cold PBS three times and 
lysed in a buffer containing 50 mM Tris-HCl, pH 
7.4, 1 % (v/v) Tergitol- type NP-40 (NP-40), 0.25 
% sodium deoxycholate, 150 mM NaCl, 1 mM 
EDTA, 25 mM NaF, 2 mM sodium orthovanadate 
(Na3VO4) and protease inhibitor cocktail 
(Complete MiniTM, Roche, Mannheim, Germany) 
at 4 °C. The lysate was clarified by centrifugation 
at 10,000 x g for 20 min at 4 °C to remove 
insoluble components. Cell lysates were 
normalized for protein content using 
bicinchoninic acid (BCA) reagent (Pierce, 
Rockford, IL, USA). Equal amounts of protein 
were loaded onto 10 % poly acryl amide gel 
electrophoresis (PAGE) and separated by 
standard sodium dodecyl sulphate (SDS)-PAGE 
procedure. Proteins were transferred to an NC 
membrane (S&S, Dassel, Germany) and blocked 
with 5 % non-fat dry milk in TBS. To detect 
protein expression, the blots were probed with 
the specific antibodies followed by the secondary 
antibodies coupled to horseradish peroxidase 
(Bio-Rad, Herculus, CA, USA) with β-actin as 
internal control. The immunoreactive proteins on 
the membrane were detected by 
chemiluminescence using the West-Save 
substrate (Lab-Frontier, Seoul, Korea) on X-ray 
film. The antibodies against inducible nitric oxide 
synthase (iNOS), cyclooxegenase (COX) -1, 
COX-2, nuclear factor kappa-B (NF-κB), I kappa 
B-alpha (IκB-α), on extracellular signal-regulated 
kinase (ERK 1/2) and β-actin were purchased 
from Cell (Beverly, MA, USA).  
 
Pro-inflammatory cytokines assay 
 
Murine BV2 microglia cells (1 x 105 cells/well) 
were cultured on 96 well plates and treated with 
the UDE at indicated concentrations for 1 h and 
stimulated with LPS (1 µg/mL). At 24 h post LPS 
treatment, the production of TNF-α and 1 h post 
IFN-ɣ treatment, the production of TNF-α were 
determined in cell supernatant using assay kits 
(BD Biosciences, San Jose, CA, USA) as per the 
manufacturer’s instructions. The pro-
inflammatory cytokines assay was performed at 
room temperature and optical absorbance at 450 




All data are presented as mean ± S.E.M of at 
least three independent experiments. Statistical 
analyses were performed by SAS statistical 
software (SAS Institute, Cray, NC, USA) using 
one-way analysis of variance, followed by 
Dunnett's multiple range tests. P-values < 0.05 




Effect of UDE on DPPH radical scavenging 
activity  
 
As shown in Fig. 1A, UDE exhibited significant 
DPPH radical scavenging activity in a dose-
dependent manner, showing a maximum effect 
at 100 μg/mL of concentration (p < 0.001). The 
ESR spectroscopy data at 10, 20, 40, 60, 80 and 
100 μg/mL are shown in Fig 1B. UDE 
significantly scavenged the DPPH free radicals. 
 
Effect of UDE on LPS-induced NO production 
 
UDE treatment did not exhibit any significant 
cytotoxicity in BV2 murine microglial cells even at 
a high concentration (100 μg/ml) up to 24 h of 
incubation, and in all cases the viability was 
found above 97 % by MTT assay (Fig 3). 
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Figure 1: Effect of UDE on DPPH radical scavenging activity on BV2 microglial cells. Data are presented as the 
mean ± S.E.M. (n = 3) for three independent experiments. ***p < 0.001, when compared with control group by 
one-way analysis of variance, followed by Dunnett's multiple range tests 
 
Figure 2: Effect of UDE on NO Production in LPS- stimulated BV2 microglial cells. BV2 cells were treated with 
UDE at 10, 20, 40, and 80 μg/ml with or without LPS (1 μg/ml) for 4 hr. Data are presented as the mean ± SEM 
(n = 3) for three independent experiments. #p < 0.001, when compared with control group. *p < 0.05, **p < 0.01 
and ***p < 0.001, when compared with LPS alone treated group by one-way analysis of variance, followed by 
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Figure 3: Effect of UDE on the viability of BV2 microglial cells. Data are presented as mean ± SEM (n=3) for 
three independent experiments 
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Effect of UDE on LPS-induced expression of 
iNOS and COX levels  
 
UDE exhibited a broad spectrum of inhibitory 
effects on the expression of pro-inflammatory 
mediators. UDE reduced the LPS-stimulated 
increase of iNOS protein expression and 
inducible COX-2 in a concentration-dependent 
manner. This results clearly showed that UDE 
attenuated LPS-induced iNOS expression and 
downstream NO production. LPS strongly 
activates microglia and induces COX-2. 
Constitutive COX-1 protein expressional levels 






Figure 4: Effect of UDE on iNOS, COX-1 and COX-2 
protein expressional levels in LPS-stimulated BV2 
microglial cells. The expression levels of iNOS, COX-1 
and COX-2 production in the LPS-stimulated BV2 cells 
at 10, 25, 50 and 100 μg/mL of UDE were monitored 






Effect of UDE on NF-κB and ERK levels  
 
UDE inhibited the LPS-induced phosphorylation 
and degradation of IκB-α, and nuclear 
translocation of p65 NF-κB in a concentration- 
dependent manner (Fig. 5). In addition, UDE 
markedly inhibited the IFN-ɣ induced 
phosphorylation of ERK after 1h stimulation (Fig. 
6). These results showed that UDE inhibited 
LPS-induced phosphorylation/degradation of 






Figure 5: Effect of UDE on nuclear factor-kappaB 
(NF-κB) activity in LPS- stimulated BV2 microglia. 
Data is presented as the mean ± SEM (n=3) for three 
independent experiments.  
 
 
Figure 6: Effect of UDE on extracellular signal-
regulated kinase (ERK) activity in IFN-γ stimulated 
BV2 microglia. Data are presented as mean ± SEM 
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Figure 7: Effect of UDE on pro-inflammatory cytokine TNF-ɣ expression in LPS-stimulated BV2 cells (A). Data is 
presented as the mean ± SEM (n = 3) for three independent experiments. #p < 0.001, when compared with 
control group. *p < 0.05, **p < 0.01, ***p < 0.001, compared with LPS only group; comparison made by one-way 
analysis of variance, followed by Dunnett's multiple range tests. Effect of UDE on pro-inflammatory cytokine 
MCP-1 expression in IFN-ɣ stimulated BV2 cells (B). Data is presented as the mean ± SEM (n = 3) for three 
independent experiments 
 
Effect of UDE on TNF-αproduction in LPS- 
stimulated BV2 cells  
 
LPS stimulation of the BV2 murine microglial 
cells increased TNF-α expression. However, 
pretreatment with UDE decreased the LPS-
induced TNF-α level in BV2 microglia (Fig. 7A). 
Pro-inflammatory cytokines such as TNF-α, IL-1β 
and IL-6 caused potent activation of iNOS gene 
expression in rodent glial cells and muscle cells 
[11]. The likelihood of the involvement of UDE in 
attenuating such factors is supported by this 
observations that pro-inflammatory mediator 
TNF-α produced by LPS treatment was 
suppressed by UDE in BV2 microglial cells 
indicating that UDE may be an effective anti-
neuroinflammatory agent.  
 
Effect of UDE on MCP-1production in IFN-ɣ 
stimulated BV2 cells  
 
Monocyte Chemo-attractant Protein-1 (MCP-1) is 
the first discovered and most extensively studied 
CC chemokine, and the number of studies on the 
etiologies of obesity and diabetes-related 
diseases has increased exponentially in the past 
two decades [12]. The roles of MCP-1 in the 
development of obesity, diabetes and 
cardiovascular diseases in metabolically healthy 
problems [12]. IFN-ɣ stimulation increased MCP-
1 expression in BV- cells, while pretreatment with 
UDE decreased the LPS-induced MCP-1 levels 




Inflammation is partially ascribed to release of 
toxic free radicals and ROS. DPPH radical 
scavenging assay is one of the widely used 
methods for screening the free radical 
scavenging activities of several agents in a 
relatively short period of time. In the present 
study, AEE significantly scavenged the DPPH 
free radicals.  In this study a pro-inflammatory 
stimulus by LPS on BV2 cells resulted in 
excessive production of NO. NO production by 
LPS-activated cells was significantly inhibited by 
UDE in a concentration-dependent manner.  
 
Excessive production of inflammatory mediators 
such as nitric oxide (NO), prostaglandin E2 
(PGE2), and proinflammatory cytokines, 
including tumor necrosis factor-alpha (TNF-α) 
and interleukin-1beta (IL-1β) from activated 
microglia contributes to uncontrolled 
inflammation in neurodegenerative diseases. It 
seems possible that treatment with anti-
inflammatory agents, including plants used in 
Oriental medicine, might delay the progression of 
neurodegeneration through the inhibition of 
microglial activation [9]. These results indicated 
that UDE significantly inhibited the excessive 
production of NO, in LPS-stimulated BV2 cells.   
 
It was well known that COX-1 is constitutively 
expressed in many cell types and COX-2 is 
normally not present in most cells, but its 
expression is induced in response to 
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events [10].  Earlier literature revealed that 
increased expression of the COX-2 plays an 
important role in the inflammatory process and 
neuro-degenerative diseases [10]. Several 
reports indicate that iNOS and COX-2 are 
induced excessively in various types of central 
nervous injuries and diseases [10]. Attenuation of 
the induction of iNOS and COX-2 in activated 
microglia can prevent neuro-inflammation. 
Although this results point to a potential role of 
UDE in inhibiting iNOS and COX-2 production, 
the possibility remains that UDE may further 
suppress other microglia-derived pro-
inflammatory factors upon LPS treatment in BV2 
cells.  
 
Pro-inflammatory cytokines such as TNF-α, IL-
1β, and IL-6 play central roles in inflammation. In 
particular, increased levels of brain TNF-α and 
IL-6 has been associated with severe cognitive 
impairments, neuronal damage and 
neuroinflammation [13]. Therefore, the effects of 
UDE on pro-inflammatory cytokine TNF- α 
production in LPS-stimulated BV2 cells were 
evaluated. LPS-stimulation increased the levels 
of TNF-α in BV2 cells. However, pretreatment 
with UDE suppressed the increased TNF-α 
production indicating that AEE may convincingly 
be an effective anti-inflammatory agent. 
 
NF-κB, a mammalian transcription factor, 
activated by LPS, is known to control the 
expression of cell survival genes as well as 
proinflammatory enzymes and cytokines [14].  
 
The molecular mechanisms that underlie UDE-
mediated attenuation are related to the inhibition 
of the phosphorylation of three mitogen-activated 
protein kinases (MAPKs), extracellular signal-
regulated kinases 1 and 2 (ERK1/2), p38 MAPK, 
and c-Jun N-terminal kinase (JNK), and the 
activation of nuclear factor-kappaB (NF-κB). Our 
result showed that AEE inhibited the LPS 
induced phosphorylation/degradation of IκB-α 
and translocation of NF-κB/p65 sub unit in a 
concentration-dependent manner. Considering 
the above data, we can conclude that NF-κB is a 
major target of UDE. However, the exact 
molecular target of UDE on NF-κB activation 




The findings of this study indicate that UDE 
inhibits anti-inflammatory responses via NF-κB 
signaling in LPS-stimulated BV2 murine cells. 
Further, the antioxidant activity of UDE may be 
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